CA2004206A1 - Methodes de preparation de l'anatoxine coquelucheuse - Google Patents

Methodes de preparation de l'anatoxine coquelucheuse

Info

Publication number
CA2004206A1
CA2004206A1 CA2004206A CA2004206A CA2004206A1 CA 2004206 A1 CA2004206 A1 CA 2004206A1 CA 2004206 A CA2004206 A CA 2004206A CA 2004206 A CA2004206 A CA 2004206A CA 2004206 A1 CA2004206 A1 CA 2004206A1
Authority
CA
Canada
Prior art keywords
pertussis toxin
toxoid
preparing
toxin toxoid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2004206A
Other languages
English (en)
Other versions
CA2004206C (fr
Inventor
Kazunori Morokuma
Katsutoshi Aihara
Mitsuo Sakoh
Akihiro Ginnaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of CA2004206A1 publication Critical patent/CA2004206A1/fr
Application granted granted Critical
Publication of CA2004206C publication Critical patent/CA2004206C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002004206A 1988-11-29 1989-11-29 Methodes de preparation de l'anatoxine coquelucheuse Expired - Lifetime CA2004206C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63303767A JP2706792B2 (ja) 1988-11-29 1988-11-29 百日咳毒素のトキソイド化法
JP303767/1988 1988-11-29

Publications (2)

Publication Number Publication Date
CA2004206A1 true CA2004206A1 (fr) 1990-05-29
CA2004206C CA2004206C (fr) 2000-02-08

Family

ID=17925036

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004206A Expired - Lifetime CA2004206C (fr) 1988-11-29 1989-11-29 Methodes de preparation de l'anatoxine coquelucheuse

Country Status (6)

Country Link
US (1) US4996299A (fr)
EP (1) EP0377114B1 (fr)
JP (1) JP2706792B2 (fr)
AT (1) ATE110279T1 (fr)
CA (1) CA2004206C (fr)
DE (1) DE68917709T2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5578308A (en) * 1990-02-12 1996-11-26 Capiau; Carine Glutaraldehyde and formalin detoxified bordetella toxin vaccine
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
BRPI0402630B8 (pt) * 2004-07-05 2021-05-25 Fund Butantan processo de obtenção de vacina pertussis celular menos reatogênica
WO2007111326A1 (fr) * 2006-03-27 2007-10-04 The Kitasato Institute Vaccin à cellules entières souffrant de non retour de toxicité même après stockage prolongé et utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
CA1213234A (fr) * 1983-03-30 1986-10-28 Akihiro Ginnaga Methode de production d'une fraction ha contenant des antigenes protecteurs de bordetella pertussis et vaccin contre la coqueluche
KR890001003B1 (ko) * 1984-07-19 1989-04-18 자이단 호오진 까가꾸 오요비 겟세이 료오호 겐뀨쇼 Lpf-ha의 정제방법
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
FR2597344B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
CA1337859C (fr) * 1987-04-24 1996-01-02 Masashi Chazono Methode pour la culture de bordetella pertussis permettant d'obtenir l'anatoxine et un vaccin de la coqueluche

Also Published As

Publication number Publication date
EP0377114B1 (fr) 1994-08-24
DE68917709T2 (de) 1995-05-04
JP2706792B2 (ja) 1998-01-28
DE68917709D1 (de) 1994-09-29
JPH02149529A (ja) 1990-06-08
ATE110279T1 (de) 1994-09-15
CA2004206C (fr) 2000-02-08
US4996299A (en) 1991-02-26
EP0377114A1 (fr) 1990-07-11

Similar Documents

Publication Publication Date Title
KR970003057B1 (en) Lyophilized pharmaceutical composition of neocarzinostatin derivative
CA2138137A1 (fr) Vaccins contre les toxines diphteriques
CA2142981A1 (fr) Vaccins contre neisseria meningitidis du groupe c
GR3018285T3 (en) Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines.
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
AU3256789A (en) Topical preparation for treating otopathy
EP0400076A4 (en) A synthetic antigen evoking anti-hiv response
GR3014900T3 (en) Affinity associated vaccine.
GR870917B (en) Novel mehthod of preparing toxoid
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
ZA91947B (en) Novel vaccine
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
HUT59136A (en) Process for producing 3-(pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
EP0427768A4 (en) Polypeptide pertussis toxin vaccine
CA2044721A1 (fr) Preparation et utilisation d'un vaccin contre streptococcus zooepidemicus extrait au moyen d'un enzyme et d'un detergent
EP0909759A3 (fr) Stéréoisomères individuelles de 7-(3-(aminoalkyl)-1-pyrrolidinyl)-quinolones en tant qu'agents antibactériens
NO892997D0 (no) Bordetella pertussis vaksine.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
ZA927861B (en) Artificial standard and control sera, processes for the preparation thereof and the use thereof.
AU3318289A (en) Pertussis toxoid vaccine
AU7719491A (en) Therapeutic compound
AU3841993A (en) Synthetic lipid a glycoconjugate antigens for use in vaccines
GR3017912T3 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same.
EP0789031A3 (fr)
EP0439129A3 (en) Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry